Synergistic interaction of magnesium and vanadate on glucose metabolism in diabetic rats

Metabolism: Clinical and Experimental

Volumn 48, Issue 6, 1999, Pages 725-731

  Matsuda, Masafumi ^a   Mandarino, Lawrence ^a   DeFronzo, Ralph A ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOGEN; INSULIN; MAGNESIUM SULFATE; VANADATE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETOGENESIS; DISEASE MODEL; DRUG EFFECT; DRUG POTENTIATION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; GLYCOLYSIS; INSULIN BLOOD LEVEL; INSULIN RESPONSE; INSULIN SENSITIVITY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

EID: 0032997343     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(99)90171-3     Document Type: Article

References (36)

1. DeFronzo RA: Lilly Lecture 1987. The triumvirate: Beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37:667-687, 1988
2. DeFronzo RA: Pathogenesis of type 2 diabetes: Metabolic and molecular implications for identifying diabetes genes. Diabetes Rev 5:177-269, 1997
3. Lockwood DH, Amatruda JM: Cellular alterations responsible for insulin resistance in obesity and type II diabetes mellitus. Am J Med 75:23-31, 1983
4. Rossetti L, DeFronzo RA, Gherzi R, et al: Effect of metformin treatment on insulin action in diabetic rats: In vivo and in vitro correlations. Metabolism 39:425-435, 1990
5. Dubyak GR, Kleinzeller A: The insulin-mimetic effect of vanadate in isolated rat adipocytes. J Biol Chem 255:5306-5312, 1980
6. Challis RAJ, Leighton B, Lozeman FJ, et al: Effect of chronic administration of vanadate to the rat on the sensitivity of glycolysis and glycogen synthesis in skeletal muscle to insulin. Biochem Pharmacol 36:357-361, 1987
7. Rossetti L, Laughlin MR: Correction of chronic hyperglycemia with vanadate, but not with phlorizin, normalizes in vivo glycogen repletion and in vitro glycogen synthase activity in diabetic skeletal muscle. J Clin Invest 84:892-899, 1989
8. Rossetti L, Giaccari A, Kelin-Robbenhaar E, et al: Insulinomimetic properties of trace elements and characterization of their in vivo mode of action. Diabetes 39:1243-1250, 1990
9. Cordera R, Andraghetti G, DeFronzo RA, et al: Effect of in vivo vanadate treatment on insulin receptor tyrosine kinase activity in partially pancreatectomized diabetic rats. Endocrinology 126:2177-2183, 1990
10. Meyerovitch H, Rothenberg P, Shechter Y, et al: Vanadate normalizes hyperglycemia in two mouse models of non-insulin dependent diabetes mellitus. J Clin Invest 87:1286-1294, 1991
11. Elberg G, Li J, Shechter Y: Vanadium activates or inhibits receptor and non-receptor protein tyrosine kinases in cell-free experiments, depending on its oxidation state. Possible role of endogenous vanadium in controlling cellular protein tyrosine kinase activity. J Biol Chem 269:9521-9527, 1994
12. Goldfine AB, Simonson DC, Folli F, et al: In vivo and in vitro studies of vanadate in human and rodent diabetes mellitus. Med Cell Biochem 153:217-231, 1995
13. Goldfine AB, Simonson DC, Folli F, et al: Metabolic effects of sodium metavanadate in humans with insulin-dependent and noninsulin-dependent diabetes mellitus: In vivo and in vitro studies. J Clin Endocrinol Metab 80:3312-3320, 1995
14. Cohen N, Halbertstam M, Shlimovich P, et al: Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 95:2501-2509, 1995
15. Cusi K, Cukier S, DeFronzo RA, et al: Vanadyl sulfate improves metabolic control and insulin sensitivity in patients with NIDDM. Diabetologia 40:A46, 1997 (suppl 1, abstr)
16. Vicario PP, Saperstein R, Bennun A: Role of divalent metals in the activation and regulation of insulin receptor tyrosine kinase. Biosystems 22:55-66, 1988
17. Paolisso G, Di Maro G, Cozzolino D, et al: Chronic magnesium administration enhances oxidative glucose metabolism in thiazide treated hypertensive patients. Am J Hypertens 5:681-686, 1992
18. Paolisso G, Sgambato S, Pizza G, et al: Improved insulin response and action by chronic magnesium administration in aged NIDDM subjects. Diabetes Care 12:265-269, 1989
19. Smith D, Rossetti L, Ferrannini E, et al: In vivo glucose metabolism in the awake rat: Tracer and insulin clamp studies. Metabolism 36:1176-1186, 1987
20. Koopmans SJ, Ohman L, Haywood JR, et al: Seven days of euglycemic hyperinsulinemia induces insulin resistance for glucose metabolism but not hypertension, elevated catecholamine levels, or increased sodium retention in conscious normal rats. Diabetes 46:1572-1578, 1997
21. Koopmans SJ, Mandarino LJ, DeFronzo RA: Time course of insulin action on tissue specific intracellular glucose metabolism in normal rats. Am J Physiol (in press)
22. Rossetti L, Giaccari A: Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake. A doseresponse euglycemic clamp study in normal and diabetic rats. J Clin Invest 85:1785-1792, 1990
23. Shechter Y: Insulin mimetic effects of vanadate: Possible implications for future treatment of diabetes. Diabetes 39:1-5, 1990
24. Meyerovitch H, Backer JM, Csermely P, et al: Insulin differentially regulates protein phosphotyrosine phosphatase activity in rat hepatoma cells. Biochemistry 31:10338-10344, 1992
25. Okumura N, Shimazu T: Vanadate stimulates D-glucose transport into sarcolemmal vesicles from rat skeletal muscles. J Biochem 112:107-111, 1992
26. Carey JO, Azevedo JL, Morris PG, et al: Okadaic acid, vanadate, and phenylarsine oxide stimulate 2-deoxyglucose transport in insulinresistant human skeletal muscle. Diabetes 44:682-688, 1995
27. Tamura S, Brown TA, Whipple JH, et al: A novel mechanism for the insulin-like effect of vanadate on glycogen synthase in rat adipocytes. J Biol Chem 259:6650-6658, 1984
28. Leighton B, Cooper GJS, DeCosta C, et al: Peroxovanadates have full insulin-like effects on glycogen synthesis in normal and insulin-resistant skeletal muscle. Biochem J 276:289-292, 1991
29. Halberstam M, Cohen N, Shlimovich P, et al: Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese non-diabetic subjects. Diabetes 45:659-666, 1996
30. Thomas AP, Diggle TA, Denton RM: Sensitivity of pyruvate dehydrogenase phosphate phosphatase to magnesium ion. Similar effect of spermine and insulin. Biochem J 238:83-91, 1986
31. Vinals F, Camps M, Testar X, et al: Effect of cations on the tyrosine kinase activity of the insulin receptor: Inhibition by fluoride is magnesium dependent. Mol Cell Biochem 171:69-73, 1997
32. 2+)-adenosine triphosphatase activity in kidney membranes from streptozocin non-insulin-dependent diabetic rats. Metabolism 43:604-613, 1994
33. Ganguly PK, Mathur S, Gupta MP, et al: Calcium pump activity of sarcoplasmic reticulum in diabetic rat skeletal muscle. Am J Physiol 251:E515-E522, 1986
34. Paolisso G, Sgambato S, Giugliano D, et al: Impaired insulin-induced erythrocyte magnesium accumulation is correlated to impaired insulin-mediated glucose disposal in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 31:910, 1988
35. 2+] homeostasis and tyrosine phosphorylation of phospholipase C gamma 2 in HL60 granulocytes. J Biol Chem 268:3357, 1993
36. Paolisso G, Sgambato S, Gambardella A, et al: Daily magnesium supplements improve glucose handling in elderly subjects. Am J Clin Nutr 55:1161-1167, 1992